Sufentanil Market

Sufentanil, sold under the brand names Dsuvia and Sufenta, is a synthetic opioid analgesic drug approximately 5 to 10 times as potent as its parent drug, fentanyl, and 500 times as potent as morphine.

Sufentanil Market contains market size and forecasts of Sufentanil (API) in global, including the following market information:

• Global Sufentanil (API) Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Sufentanil (API) Market Sales, 2017-2022, 2023-2028, (K Units)
• Global top five Sufentanil (API) companies in 2021 (%)

The global Sufentanil (API) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Purity 98% Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Sufentanil (API) include Kern Pharma, Cambrex, Hameln Rds, Cristalia and Janssen Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Sufentanil (API) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Sufentanil (API) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Sufentanil (API) Market Segment Percentages, by Type, 2021 (%)

• Purity 98%
• Purity 99%

Global Sufentanil (API) Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Sufentanil (API) Market Segment Percentages, by Application, 2021 (%)

• Injection
• Capsule

Global Sufentanil (API) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Sufentanil (API) Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Sufentanil (API) revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Sufentanil (API) revenues share in global market, 2021 (%)
• Key companies Sufentanil (API) sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Sufentanil (API) sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Kern Pharma
• Cambrex
• Hameln Rds
• Cristalia
• Janssen Pharmaceuticals